Spatiotemporal tracking of the transport of RNA nano-drugs: from transmembrane to intracellular delivery
Source abstract
Abstract
The popularity of RNA nanoparticles (RNPs) has risen rapidly during the past decade due to the development of RNA nanotechnology. Understanding the fast dynamic process of cell entry and intracellular delivery of RNPs is essential for the design of intelligent therapeutic RNA nano-drugs and mRNA vaccines.How the interaction between the membrane and target ligand of RNPs influences the cell entry, and how the dynamic mechanism of RNPs takes place in different organelles remain ill-defined. Herein, the cell entry of Antimir21-RNP-Apt is monitored using a force tracing technique with a high spatiotemporal resolution at the single particle level, the specific interaction of Apt and EGFR promotes the cell entry efficiency and achieves long-lasting curative effects. Furthermore, the intracellular delivery pathway through different organelles is discovered using fluorescence tracking, and the low motility in early endosomes and the high motility in late endosomes are analyzed. This report provides key strategies for engineering RNA nanomedicines and facilitating clinical translation.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · RNA and protein synthesis mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemistry and Life Science, Advanced Institute of Materials Science, Changchun University of Technology, Changchun 130012, China
Changchun Institute of Applied Chemistry, State Key Laboratory of Electroanalytical Chemistry, Chinese Academy of Science, Changchun 130022, China
Funding
Outstanding Young Talent Foundation of Jilin Province · Education Department of Jilin Province · National Natural Science Foundation of China
References (53)
Show source-provided references
1. Chernikov · Front. Pharmacol. · 2019 · 10 · 44410.3389/fphar.2019.00444 ↗
2. Hu · Signal Transduction Targeted Ther. · 2020 · 5 · 10110.1038/s41392-020-0207-x ↗
3. Lam · Mol. Ther.–Nucleic Acids · 2015 · 4 · e25210.1038/mtna.2015.23 ↗
4. Kaczmarek · Genome Med. · 2017 · 9 · 6010.1186/s13073-017-0450-0 ↗
5. Binzel · Chem. Rev. · 2021 · 121 · 739810.1021/acs.chemrev.1c00009 ↗
6. Guo · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2020 · 12 · e1582
7. Jasinski · ACS Nano · 2017 · 11 · 114210.1021/acsnano.6b05737 ↗
8. Guo · Mol. Ther.–Nucleic Acids · 2017 · 9 · 39910.1016/j.omtn.2017.10.010 ↗
9. Rychahou · ACS Nano · 2015 · 9 · 110810.1021/acsnano.5b00067 ↗
10. Piao · Adv. Sci. · 2019 · 6 · 190095110.1002/advs.201900951 ↗
11. Shu · ACS Nano · 2015 · 9 · 973110.1021/acsnano.5b02471 ↗
12. Jackson · N. Engl. J. Med. · 2020 · 383 · 192010.1056/NEJMoa2022483 ↗
13. Maruggi · Mol. Ther. · 2019 · 27 · 75710.1016/j.ymthe.2019.01.020 ↗
14. Pardi · Nat. Rev. Drug Discovery · 2018 · 17 · 26110.1038/nrd.2017.243 ↗
15. Heine · Mol. Cancer · 2021 · 20 · 5210.1186/s12943-021-01339-1 ↗
16. Zhang · Front. Immunol. · 2019 · 10 · 59410.3389/fimmu.2019.00594 ↗
17. Castells · N. Engl. J. Med. · 2021 · 384 · 64310.1056/NEJMra2035343 ↗
18. Turner · Nature · 2021 · 596 · 10910.1038/s41586-021-03738-2 ↗
19. Jhaveri · Expert Opin. Drug Delivery · 2016 · 13 · 4910.1517/17425247.2015.1086745 ↗
20. Vtyurina · Nanoscale · 2021 · 13 · 1043610.1039/D1NR00901J ↗
21. Durymanov · Front. Pharmacol. · 2018 · 9 · 97110.3389/fphar.2018.00971 ↗
22. Guo · Nat. Nanotechnol. · 2010 · 5 · 83310.1038/nnano.2010.231 ↗
23. Bareford · Adv. Drug Delivery Rev. · 2007 · 59 · 74810.1016/j.addr.2007.06.008 ↗
24. Rennick · Nat. Nanotechnol. · 2021 · 16 · 26610.1038/s41565-021-00858-8 ↗
25. Kulkarni · Nat. Nanotechnol. · 2021 · 16 · 63010.1038/s41565-021-00898-0 ↗
26. Pan · Small · 2015 · 11 · 278210.1002/smll.201403491 ↗
27. Zhang · ACS Nano · 2020 · 14 · 704610.1021/acsnano.0c01739 ↗
28. Chen · Global Challenges · 2020 · 4 · 190007510.1002/gch2.201900075 ↗
29. Nakano · Cell Struct. Funct. · 2002 · 27 · 34910.1247/csf.27.349 ↗
30. Thorn · Methods Enzymol. · 2010 · 470 · 58110.1016/S0076-6879(10)70023-9 ↗
31. Xu · Anal. Chem. · 2020 · 92 · 655510.1021/acs.analchem.0c00197 ↗
32. Volovat · Front. Oncol. · 2020 · 10 · 52685010.3389/fonc.2020.526850 ↗
33. Guo · Acta Pharm. Sin. B · 2019 · 9 · 83210.1016/j.apsb.2019.01.012 ↗
34. Zhou · Front. Genet. · 2012 · 3 · 23410.3389/fgene.2012.00234 ↗
35. Galochkina · Sci. Rep. · 2019 · 9 · 99810.1038/s41598-018-37367-z ↗
36. Zhao · PLoS One · 2014 · 9 · e9159510.1371/journal.pone.0091595 ↗
37. Liu · J. Mater. Chem. B · 2021 · 9 · 95210.1039/D0TB02527E ↗
38. Zhang · Anal. Chem. · 2015 · 87 · 996010.1021/acs.analchem.5b02572 ↗
39. Tomas · Trends Cell Biol. · 2014 · 24 · 2610.1016/j.tcb.2013.11.002 ↗
40. Tuli · Front. Pharmacol. · 2019 · 10 · 133610.3389/fphar.2019.01336 ↗
41. Chang · Mol. Ther.–Methods Clin. Dev. · 2014 · 1 · 1405810.1038/mtm.2014.58 ↗
42. Wang · ACS Nano · 2022 · 16 · 405910.1021/acsnano.1c09684 ↗
43. Zhang · RSC Adv. · 2018 · 8 · 2179310.1039/C8RA03215G ↗
44. Malefyt · Nano LIFE · 2012 · 2 · 124100510.1142/S179398441241005X ↗
45. Xu · Chem. Res. Chin. Univ. · 2021 · 37 · 82910.1007/s40242-021-1191-6 ↗
46. Huotari · EMBO J. · 2011 · 30 · 348110.1038/emboj.2011.286 ↗
47. Cioni · Cell · 2019 · 176 · 5610.1016/j.cell.2018.11.030 ↗
48. Zhang · Biophys. Rep. · 2021 · 7 · 38410.52601/bpr.2021.210018 ↗
49. Zhou · Chin. J. Anal. Chem. · 2020 · 48 · 174
50. Falk · J. Neurosci. · 2014 · 34 · 37310.1523/JNEUROSCI.0876-13.2014 ↗
51. Zajac · Curr. Biol. · 2013 · 23 · 117310.1016/j.cub.2013.05.015 ↗
52. Pan · Nanoscale Horiz. · 2018 · 3 · 51710.1039/C8NH00056E ↗
53. Zeng · Biomacromolecules · 2012 · 13 · 381410.1021/bm301281k ↗